3098 Nivolumab (NIVO) monotherapy or in combination with ipilimumab (IPI) for treatment of recurrent small cell lung cancer (SCLC). (September 2015) - Calvo, E.; López-Martin, J.A.; Bendell, J.; Eder, J.P.; Taylor, M.; Ott, P.A.; Pietanza, M.C.; Horn, L.; Jäger, D.; Braud, F. De; Morse, M.A.; Ascierto, P.A.; et al.